- Home
- Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT
- Antios Therapeutics Doses First Patients in SAVE 1, a Phase 2a Study of ATI-2173 in Patients with Ch
- Fractyl Health Publishes Two-Year Durability Data After a Single Revita DMR® Therapeutic Procedure i